Navigation Links
Effective Strategies for Managing Comparator Product Testing, New Webinar Hosted by Xtalks
Date:3/6/2013

Toronto, Canada (PRWEB) March 06, 2013

Before a product within the same therapeutic class as another can be released to the market, comparator product testing must be performed to confirm that the product’s benefits outweigh that of the current, comparable product on the market.
Most oral solid dosage form products are over-encapsulated for blinded clinical studies, which can present various challenges, including: product sourcing, developing stability indicating methods, and determining the best methods for blinded clinical studies.

The key to a successful comparator product testing project is allowing enough time to successfully complete the entire method development and validation process prior to study set-down in order to eliminate any risk of product-release delays due to unnecessary method-related result failures.

Join keynote speakers Nathan T. Whitford, Manager of Chemistry and Site Operations, Eurofins Lancaster Laboratories, Inc, Jutta Wagner, Head of Project Management Manufacturing at Fisher Clinical Services, and Chrissy Leslie, Manager of Pharmaceutical Product Testing with Eurofins Lancaster Laboratories, Inc.

During this presentation, attendees will learn current strategies and best practices for comparator product testing, including:

  •     Strategies for sourcing and manufacturing.
  •     Processes for method development.
  •     Tactics and challenges associated with stability studies including cross linking.
  •     Tools to develop realistic timelines for successful project completion.

For more information about this event or to register, visit: http://xtks.in/xto563-event

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10489403.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Tips for Effective Natural Alternatives to Pain Medications
2. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
3. Cost-Effective Approaches to Quality Distribution and Logistics for Temperature Sensitive Products
4. My Cleaning Products Compiles Pictures of Bed Bugs, Shares How to Use Them Effectively to Eliminate the Pests
5. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
6. Penn metamaterials experts show a way to reduce electrons effective mass to nearly 0
7. Bed Bugs Find Their Way to University of Washington and Hastings-on-Hudson Libraries; Bed Bug Control 911 Advises Use of Bed Bug Spray to Effectively Clear the Pests Away
8. Queens Volunteer Firefighters Receive Mold Removal Training; IgotMold Recommends Use of Molderizer to Make the Process Effective and Safe
9. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
10. Possible Mold Infestation at Queens School Worries Parents; Doctor Mold Network Suggests a Mold Spray for a Safe and Effective Mold Remediation Process
11. Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... and BEIJING , Nov. 30, 2016 ... provider of genomic services and solutions with cutting edge ... it has completed a USD $75 Million [515 Million ... Ltd.,s CMB International Capital Management ( Shenzhen ... Co., Ltd. ("SDIC Innovation") and Shanghai Sigma Square Investment ...
(Date:11/30/2016)... , Nov. 30, 2016   Merck , ... it has entered into a set of agreements with ... for Merck,s collection of genetic reagents such as CRISPR ... Evotec,s screening expertise offers an accelerated pathway to explore ... starts with the identification of new targets, a process ...
(Date:11/30/2016)... ... November 30, 2016 , ... T3D Therapeutics, Inc., a clinical ... treatment for Alzheimer’s disease (AD), today announced that CEO, John Didsbury, will be ... T3D-959 in mild to moderate Alzheimer’s patients at CTAD 2016. Preliminary results of ...
(Date:11/30/2016)... Toronto, ON (PRWEB) , ... November 30, 2016 ... ... focused on discovery and development of precision treatments for neurodegenerative diseases, today announced ... disease (AD) (announced on November 3, 2016) blocked propagation of toxic, prion-like forms ...
Breaking Biology Technology:
(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/14/2016)... 14, 2016  xG Technology, Inc. ("xG" or the ... wireless communications for use in challenging operating environments, announced ... 2016. Management will hold a conference call to discuss ... Eastern Time (details below). Key Recent Accomplishments ... million binding agreement to acquire Vislink Communication Systems. The ...
Breaking Biology News(10 mins):